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The effects of interleukin (IL)-la, IL-I/? and TNFa on prostaglandinE2 synthesis in Madin-Darby canine kidney (MDCK) cells were investigated. 
IL-lb time- and dose-dependently stimulated prostaglandin-E2 synthesis. While TNFa produced a comparatively small but significant stimulation 
of PGE2 release, coincubation of IL-IS with TNFa produced a marked synergistic stimulation of PGE2 release. The effect of IL-1B and of IL-IS 
and TNFa was apparent as early as after 2 h of incubation. The enhanced PGE2 synthesis was inhibited by indomethacin as well as actinomycin 
D, while cycloheximide surprisingly potentiated PGE2 synthesis in response to both IL-l/I and TNFa. IL-la alone was ineffective in stimulating 
a significant release of PGE2 at concentrations as high as 10 nM. However, it also showed a marked synergistic interaction with TNFa in stimulating 
PGE2 release. 
Interleukin-1; TNFa; Prostaglandin-E2; Madin-Darby canine kidney cell; Cycloheximide 
1. INTRODUCTION DMEM/HAM’s F12 (1: i), 10% FCS, 2 mM glutamine, 1 mM 
sodium pyruvate, penicillin 50 U/ml, and streptomycin 50 pg/ml. 
It is well established that IL-l plays an important role 
in the mediation of inflammatory responses, being 
released mainly by stimulated macrophages and exer- 
ting a range of effects on many different cell types 
[l-3]. One of the effects exerted by IL-l is the stimula- 
tion of prostaglandin synthesis. Released prostaglandin 
may be an important effector in inflammation and 
pathological development in diseased kidney states. 
Markedly increased arachidonic acid metabolism is 
found in several models of renal disease [4]. Studies 
have shown a natriuretic effect of IL-l in rats that is in- 
hibitable by prior administration of indomethacin [5]. 
Stimulated PGE2 release by IL-l has also been 
demonstrated in rat renal mesangial cells [6,7]. TNFcv is 
also well known to mediate inflammatory responses, 
sharing many of IL-l’s effects and often acting 
synergistically with IL-l in vitro and in vivo in inducing 
various responses, including prostaglandin synthesis 
[8]. In this paper, we report IL-I- and TNFa-induced 
PGE2 synthesis in Madin-Darby canine kidney 
(MDCK) cells, a kidney epithelial cell line with many 
characteristics of distal tubule cells [9]. 
2.2. Incubation of cells 
Cells were plated in 16 mm diameter wells and used for experiments 
when confluent. Cells were washed twice with PBS and incubated 
with DMEM containing 0.1 mg/ml of fatty acid-free bovine serum 
albumin (Sigma) with or without agents. At the indicated times, 
medium was removed and stored at -20°C until determination of 
PGE2 by radioimmunoassay (New England Nuclear). 
2.3. Cytoxicity 
A possible cytotoxic effect of the tested compounds was checked 
with a calorimetric assay. The uptake of 3-(4,5-dimethylthiazol-2-yl)- 
2,5-diphenyl tetrazolium bromide (MIT) into MDCK cells and its 
modification to a colored product by living cells was measured as 
described [lo]. 
2.4, Chemicals 
r-IL-la (> 10’ U/mg) was obtained from Biogen, Geneva. r-IL-B 
(> IO’ U/ml) was from Biotechnology Department of Ciba-Geigy, 
Basel, Switzerland. rTNFcv (>2 x 10’ U/mg) was obtained from 
Boehringer Mannheim, FRG. Cycloheximide, actinomycin D and 
MTT were obtained from Sigma, and indomethacin was obtained 
from Ciba-Geigy, Basel. 
3. RESULTS 
2. MATERIALS AND METHODS 
2.1. Cell culture 
MDCK cells from the American Type Culture Collection in 
passages 93-100 were used and grown in medium consisting of 
Correspondence address: J. Pfeilschifter, Ciba-Geigy Ltd., 
R-1056.P.23, CH-4002 Basel, Switzerland 
Abbreviations IL-l, interleukin-I; TNF, tumor necrosis factor; 
PGE2, prostaglandin E2 
Cells incubated for 24 h with 1 nM IL-ID showed a 
more than 5-fold increase in PGE2 release over control 
cells (fig. 1). Cells incubated with IL-la at the same con- 
centration did not show a significant increase in PGE2 
release. Incubation with 1 nM TNFcv resulted in a 
moderate 1.9-fold increase. Coincubation of 1 nM 
IL-ID with 1 nM TNFcv dramatically boosted PGE2 
release by over 20-fold, while coincubation of 1 nM 
IL-la and 1 nM TNFcY produced a nearly 5-fold in- 
crease in PGE2 release. 
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Fig.1. Effect of different cytokines on PGE2 synthesis in MDCK 
cells. PGE2 synthesis in control cells was 42 + 2 pg/106 cells. Values 
are means from 4 experiments + SE. 
IL-lb and TNFa alone did not show significant stim- 
ulation of PGE2 release at concentrations below 1 nM 
(fig.2), while increasing the concentration from 1 nM to 
10 nM, the highest concentration tested, produced an 
increased stimulation of PGE2 synthesis. IL-la, which 
was ineffective at 1 nM, also showed no clearly signifi- 
cant stimulation of PGE2 release at 10 nM (data not 
shown). 
A time-course was performed on cells incubated with 
IL-1P (1 nM) or IL-l,& (1 nM) and TNFcr (1 nM) 
(fig.3). No significant stimulation of PGE2 release was 
seen during the first hour. PGE2 was released between 
the l- and 3-h time points, after which a plateau was 
reached that lasted for the remainder of the 24-h in- 
cubation. 
The cyclooxygenase inhibitor indomethacin, at a con- 
centration of 200 nM, expectedly inhibited stimulation 
of PGE2 synthesis when incubated simultaneously with 
IL-lfl (1 nM), TNFa (1 nM), or the combination 
(fig.4). The inhibitor of transcription actinomycin D, at 
cvmum (W 
Fig.2. Dose dependency of different cytokines on PGE2 synthesis in 
MDCK cells. Cells were stimulated for 24 h with (0), IL-lp; (o), 
TNF~Y; (A), IL-la and TNFcr. Values are means from 4 experiments 
f SE. 
Fig.3. Time-course of cytokine-stimulated POE2 synthesis in MDCK 
cells. Cells were stimulated with (O), vehicle; (#, IL-l,6 (1 nM); (A), 
IL-l,8 (1 nM) + TNFw (1 nM). Values are means from 4 experiments 
f SE. 
a concentration of 10 PM, also effectively maintained 
PGE2 release at or near control values, which, along 
with the initial time lag in PGE2 release, indicates the 
involvement of de novo protein synthesis in the stimula- 
tion of PGE2 synthesis. However, when the cytokines 
were coincubated for 24 h with the translation inhibitor 
cycloheximide at a concentration of 10 PM, there was a 
marked augmentation of PGE2 release. This effect was 
especially dramatic with TNFcu, with cycloheximide 
boosting PGE2 release more than 50-fold over that in- 
duced by TNFa alone. A time-course of combined 
TNFa and cycloheximide stimulation of PGE2 syn- 
thesis revealed a biphasic effect, with a relatively small 
synergistic increase at 4 h that plateaued for at least 4 h, 
and a dramatic increase between 8 and 24 h (fig.5). 
It is known that cycloheximide can sensitize some 
cells which are normally resistant o TNFa-cytotoxicity 
[ 111. To test for a possible cytotoxic effect, an MTT in- 
corporation assay was performed following a 24-h in- 
cubation with different agents. Combined incubation 
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Fig.4. Effect of different compounds on cytokine-stimulated PGE2 
synthesis in MDCK cells. Cells were incubated for 24 h with the in- 
dicated concentrations of cytokines + (A), vehicle; (B), cyclohex- 
imide (10pM); (C), actinomycin D (10 NM); (D), indomethacin 
(200 nM). Values are means from 4 experiments t SE. 
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Fig.5. Time-course of cyclohe~mide-induced potent&ion of TNFru- 
stimulated PGE2 synthesis in MDCK cells. Ceils were incubated for 
the indicated time periods with (0), vehicle; (o), cycloheximide 
(1OpM); (A), TNFcv (1 nM); (A), cycloheximide (10,&l) f TNFcv 
(1 nM). Values are means from 4 experiments 2 SE. 
with 10 PM cycloheximide and 1 nM TNFcv resulted in 
a 70% drop in cell survival, whereas neither agent alone 
exhibited cytotoxicity. In a further experiment, the 
cyclooxygenase inhibitor indomethacin was coin- 
cubated with TNFcv and cycloheximide in order to 
determine whether prostaglandin synthesis is required 
for the cytotoxic effect. As has been reported with other 
cell types by others [12,13], indomethacin did not pro- 
tect the ceils from the cytotoxicity of TNFa and cyclo- 
heximide (data not shown). These results suggest hat 
the large stimulation of PGE2 synthesis by cyclohex- 
imide and TNFcv is a consequence of cell injury, al- 
though a separate parallel mechanism cannot be ruled 
out. An MTT incorporation assay was also performed 
following a 24-h incubation with IL-W (I nM) and 
cycloheximide (lOaM). Contrary to the findings with 
TNFa, no significant cytotoxicity was observed. Cell 
death can therefore probably be excluded as an ex- 
planation for the moderate potentiation of IL-W- 
stimulated PGE2 synthesis by cycloheximide. 
4. DISCUSSION 
The present study demonstrates a time- and dose- 
dependent stimulation of PGE2 synthesis in MDCK 
cells by IL-lfl, low-level stimulation by TNFcr, and a 
marked synergistic stimulation by IL-l@ and TNFcv and 
by IL-la and TNFcr. These findings of IL-l- and 
TNFcY-stimulated PGE2 synthesis are similar to those 
found in renal mesangial cells, where a synergistic inter- 
action was also found, and IL-l,& was found to be much 
more potent than IL-la [‘7]. However, the time-course 
is different in the present study, with PGE2 synthesis 
occurring early and over a relatively short period, com- 
pared with the 8-h time lag and prolonged synthesis 
found in mesangial cells. In addition, the cycloheximide 
potentiation of the stimulation of PGE2 synthesis by 
both IL-lfl and TNFcv is a new finding. Renal 
eicosanoids in general have been shown to affect such 
processes as renal blood flow, renin release, and water 
and ion reabsorption [4]. PGEZ in particular is impor- 
tant for its role as a vasodilator. PGE2 has also been 
shown to modulate CAMP levels in many cells, in- 
cluding MDCK cells [9,14], which may in turn negative- 
ly regulate PGE2 synthesis [15]. Secreted PGE2 has 
been suggested to feedback on IL-1 production by in- 
vasive macrophages [4,16], and there is also evidence 
that it suppresses macrophage cytotoxicity [171 and Ia 
antigen expression [181. 
IL-l- and TNF-stimulation of PGE2 in MDCK cells, 
in addition to representing a response to macrophage 
invasion in the inflamed kidney, may also be relevant o 
local re~lation of PGE2 synthesis by neighboring cells 
under normal physiological conditions, as many cell 
types other than macrophages, including renal 
mesangial cells [19,20], have been shown to secrete IL-l 
and TN%. 
The stimulation of PGE2 synthesis is most likely at- 
tributable to an induction of cyclooxygenase and/or 
phospholipase A2, IL-l has been shown to stimulate 
cyclooxygenase synthesis in fibroblasts 121,221 and in- 
crease intracellular phospholipase A2 in rabbit chon- 
drocytes [23]. Similarly, TNFa! has been shown to in- 
duce phospholipase A2 and a phospholipase-activating 
protein in endothelial cells 1241. The effect of cyclohex- 
imide in potentiating the stimulation of PGE2 by IL-lfi 
and by TNFa! was unexpected. The very large increase 
in PGE2 synthesis during a 24-h incubation with both 
TNFtv and cycloheximide is most likely a consequence 
of cell injury following cycloheximide-induced suscep- 
tibility to TNFcz cytotoxicity by an as yet incompletely 
determined mechanism [15,25,26]. 
However, a smaller increase in PGE2 synthesis ob- 
servable at 4 h, after which a plateau is reached for at 
least 4 h, suggests that another mechanism of potentia- 
tion of PGE2 synthesis may be operating at earlier time 
points. Consistent with this suggestion of a second 
mechanism is the observation of a doubling in IL-l,& 
stimulated PGE2 synthesis by coincubation with cyclo- 
heximide (fig.4), which is not due to a cytotoxic effect. 
The explanation for this result is not entirely clear, but 
may involve a labile repressor protein whose disap- 
pearance allows a greater stimulation by IL-l@ and 
TNFm of the transcription of a cyclooxygenase or phos- 
phohpase A2 gene. Cycloheximide-stimulation of 
mRNA synthesis has been reported for several genes, 
including the humanp-interferon genes [27], mouse ac- 
tin genes [28], and immunoglobulin k-light-chain genes 
f29], and the stimulatory effect of cycloheximide has in 
several cases been traced to specific &-regulatory 
elements [30-321, although the regulatory proteins in- 
volved are far more elusive. 
Negative transcriptional regulation by trans-acting 
factors has been shown to play an important part in 
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eukaryotic gene regulation [33,34], and the present 
findings suggest hat such regulation may also play a 
role in the control of prostaglandin synthesis, at least in 
certain tissues. measurement of cyclooxygenase and 
phospholipase A2 mRNA levels would be an important 
next step in elucidating the effect of cycloheximide on 
IL- lb- and TNFcu-stimulated PGE2 synthesis. 
~c~~ow~e~ge~e~~~~ MDCK cells were a kind gift of Florian Lang and 
Markus Paulmichl of Innsbruck. 
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